2m 2m 2m 2m 2m 2m 2m
Medicus Pharma (MDCX)
NASDAQ
$2.60-$0.02 (-0.69%)
Price as of Oct 22, 2026 8:00 PM EDT- $4.0MMarket Cap
- -97.75%1-Year Change
- Drug Manufacturers - GeneralIndustry
Medicus Pharma (MDCX)
$2.60-$0.02 (-0.69%)
MDCX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.62 | ||
Change | -$0.04 (-1.47%) | ||
Open | $2.70 | ||
High | $2.80 | ||
Low | $2.57 | ||
Previous Close | $2.68 | ||
Volume | 44,256 | ||
30-Day Average Volume | 82,657 | ||
1-Week Change | -14.10% | ||
1-Month Change | -68.65% | ||
1-Year Change | -97.75% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.5M | ||
Total Assets | $27.1M | ||
Market Cap | $4.0M | ||
Enterprise Value | $10.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.6M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$11.4M | ||
EBITDA | -$11.4M | ||
Net Working Capital | $6.1M | ||
EPS | -$10.50 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -2 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 10/12/2026 | ||
Earnings & Revenue